loading

Quince Therapeutics Inc Borsa (QNCX) Ultime notizie

pulisher
09:26 AM

Quince Therapeutics price target raised to $5 from $4 at D. Boral Capital - Yahoo Finance

09:26 AM
pulisher
04:56 AM

Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia - BioSpace

04:56 AM
pulisher
Dec 15, 2025

QNCX Sees Increased Price Target Amidst Maintained Buy Rating | - GuruFocus

Dec 15, 2025
pulisher
Dec 15, 2025

Quince Therapeutics (NASDAQ:QNCX) Price Target Raised to $5.00 at D. Boral Capital - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Quince marks final patient visit in NEAT phase 3 study - marketscreener.com

Dec 15, 2025
pulisher
Dec 15, 2025

Quince Marks Final Patient Visit in NEAT Phase 3 Study - TradingView — Track All Markets

Dec 15, 2025
pulisher
Dec 15, 2025

Quince Therapeutics (QNCX) Concludes Phase 3 Trial for Key Drug - GuruFocus

Dec 15, 2025
pulisher
Dec 11, 2025

Citizens reiterates Market Outperform rating on Quince Therapeutics stock By Investing.com - Investing.com Canada

Dec 11, 2025
pulisher
Dec 11, 2025

Quince Therapeutics publishes early-stage data on eDSP drug delivery system - Investing.com Nigeria

Dec 11, 2025
pulisher
Dec 11, 2025

Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders - BioSpace

Dec 11, 2025
pulisher
Dec 11, 2025

Citizens reiterates Market Outperform rating on Quince Therapeutics stock - Investing.com India

Dec 11, 2025
pulisher
Dec 10, 2025

Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonar - pharmiweb.com

Dec 10, 2025
pulisher
Dec 10, 2025

Quince Therapeutics (QNCX) Publishes Promising Early Clinical Study Results - GuruFocus

Dec 10, 2025
pulisher
Dec 08, 2025

Check out these key findings about Quince Therapeutics Inc (QNCX) - setenews.com

Dec 08, 2025
pulisher
Dec 05, 2025

Trading Action: Is Quince Therapeutics Inc stock a safe buy before earnings2025 Price Momentum & Accurate Trade Setup Notifications - moha.gov.vn

Dec 05, 2025
pulisher
Dec 02, 2025

Quince Therapeutics, Inc. (QNCX) -11.5% in After-hours: No Clear Catalyst Driving Decline - Stocks Telegraph

Dec 02, 2025
pulisher
Dec 02, 2025

Quince Therapeutics, Inc. (QNCX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Dec 02, 2025
pulisher
Dec 02, 2025

Why Quince Therapeutics Inc. stock is trending among retail traders2025 Performance Recap & Real-Time Buy Signal Alerts - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Why Quince Therapeutics Inc. stock remains resilientWeekly Investment Recap & Weekly Top Stock Performers List - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Quince Therapeutics (QNCX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Dec 01, 2025

Prepare Yourself for Liftoff: Quince Therapeutics Inc (QNCX) - Setenews

Dec 01, 2025
pulisher
Nov 27, 2025

Quince Therapeutics Stock Surges 105%, With A 8-Day Winning Spree - Trefis

Nov 27, 2025
pulisher
Nov 26, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives $8.00 Consensus Target Price from Analysts - Defense World

Nov 26, 2025
pulisher
Nov 26, 2025

Quince Therapeutics, Inc. (QNCX) 18.8% in Intraday Trading: Surge Amid Upcoming Investor Events - Stocks Telegraph

Nov 26, 2025
pulisher
Nov 26, 2025

Quince Therapeutics Stock Rockets 59% With 7-Day Winning Streak - Trefis

Nov 26, 2025
pulisher
Nov 26, 2025

Quince Therapeutics: Could NEAT Phase 3 Data Deliver The First Therapy For Ataxia-Telangiectasia? - RTTNews

Nov 26, 2025
pulisher
Nov 25, 2025

Adversity is less terrifying than hope: Quince Therapeutics Inc (QNCX) - Setenews

Nov 25, 2025
pulisher
Nov 24, 2025

EBITDA per share of Quince Therapeutics, Inc. – NASDAQ:QNCX - TradingView

Nov 24, 2025
pulisher
Nov 24, 2025

Quince Therapeutics to Participate at Investor Events in December 2025 - Markets Financial Content

Nov 24, 2025
pulisher
Nov 23, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Nov 23, 2025
pulisher
Nov 21, 2025

Is Quince Therapeutics Inc. stock a dividend growth opportunity2025 Historical Comparison & Growth Oriented Trade Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

A new trading data show Quince Therapeutics Inc (QNCX) is showing positive returns. - setenews.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can Quince Therapeutics Inc. stock weather global recessionWeekly Stock Recap & Detailed Earnings Play Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Sentiment analysis tools applied to Quince Therapeutics Inc.Quarterly Portfolio Report & Weekly High Conviction Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How analysts rate Quince Therapeutics Inc. stock todayM&A Rumor & Low Risk Entry Point Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Statistical indicators supporting Quince Therapeutics Inc.’s strengthGDP Growth & Technical Entry and Exit Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Quince Therapeutics Inc. stock double in next 5 yearsMarket Trend Review & Weekly Hot Stock Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Combining machine learning predictions for Quince Therapeutics Inc.Global Markets & Daily Chart Pattern Signal Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Quince Therapeutics Inc. stock a good choice for value investorsMarket Risk Summary & Risk Managed Investment Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How interest rate cuts could boost Quince Therapeutics Inc. stockShort Setup & Daily Oversold Stock Bounce Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What indicators show strength in Quince Therapeutics Inc.July 2025 Levels & Weekly High Return Opportunities - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Quince Therapeutics Inc. stock oversold or undervaluedJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com

Nov 19, 2025
$38.53
price up icon 0.42%
$98.38
price down icon 0.32%
$31.57
price up icon 0.83%
$93.57
price down icon 0.31%
biotechnology ONC
$300.09
price down icon 5.87%
$196.92
price down icon 1.22%
Capitalizzazione:     |  Volume (24 ore):